111969 ⎘
Bacteriophages; Details dsDNA Bacteriophages New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
BACTERIA-TARGETING CAPSID PARTICLE, TREATMENT COMPOSITION, DISINFECTANT, FOOD, BACTERIA ELIMINATION METHOD, BACTERICIDAL METHOD, CORROSION PREVENTION METHOD, ANIMAL TREATMENT METHOD, GENE INTRODUCTION METHOD, BACTERIA FUNCTION ADDITION METHOD, METHOD FOR PRODUCING BACTERIA-TARGETING CAPSID PARTICLE, AND METHOD FOR PRODUCING NUCLEIC ACID FOR BACTERIA-TARGETING CAPSID PARTICLE
#2PHAGE COMPOSITIONS FOR ESCHERICHIA COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#3BACTERIOPHAGE
#4SYNTHETIC VIRUS AND PROVISION THEREOF
#5LYTIC PHAGE WITH HIGH SPECIFICITY TOWARDS PATHOGENIC ESCHERICHIA COLI
#6GENETICALLY MODIFIED PHAGES AND USES THEREOF
#7ENGINEERED CHIMERIC ANTIMICROBIAL AGENTS AGAINST GRAM-POSITIVE BACTERIA
#8A NOVEL PHAGE FOR LISTERIA, INCLUDING LISTERIA MONOCYTOGENES
#9PRODUCTION AND FUNCTIONALIZATION OF NANOPARTICLES DERIVED FROM PHAGE T5 AND THERAPEUTIC USES
#10CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST
#11ENGINEERED BACTERIOPHAGE T4 NANOPARTICLES AS A POTENTIAL TARGETED ACTIVATOR OF HIV-1 LATENCY IN CD4+ HUMAN T-CELLS
#12SITE SPECIFIC RECOMBINASE INTEGRASE VARIANTS AND USES THEREOF IN GENE EDITING IN EUKARYOTIC CELLS
#13ACINETOBACTER BAUMANNII BACTERIOPHAGE MIKAB48 OR LYTIC PROTEIN DERIVED FROM THE BACTERIOPHAGE
#14Vaccines and vaccine components for inhibition of microbial cells
#15Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
#16Vaccines and vaccine components for inhibition of microbial cells
#17Anti-CRISPR genes and proteins and methods of use
#18Phage-mediated manipulation of
#19Dimeric bacteriophage lysins
#20Vaccines and vaccine components for inhibition of microbial cells
#21Dimeric bacteriophage lysins
#22Antibacterial phage, phage peptides and methods of use thereof
#23Dimeric bacteriophage lysins
#24Phage display
#25Phage-associated lytic enzymes for treatment of and related conditions
#26Drug delivery nanocarriers targeted by landscape phage
#27Antibacterial phage, phage peptides and methods of use thereof
#28Methods and compositions for treating conditions
#29Protein purification tags and uses thereof
#30Vaccines and vaccine components for inhibition of microbial cells
#31Phage φmru polynucleotides and polypeptides and uses thereof
#32Cell-permeabilising peptides and polypeptides for microbial cells
#33Methods and compositions for treating conditions
#34Method and means for enrichment, removal and detection of gram-positive bacteria
#35Methods of selecting internalizing antibodies
#36Chimaeric phages
#37NOVGEL METHODS FOR DISPLAYING (POLY)PEPTIDES/PROTEINS ON BACTERIOPHAGE PARTICLES VIA DISULFIDE BONDS
#38Methods for modulating activities in plants
#39Chimeric Bacteriophages, Chimeric Phage-Like Particles, and Chimeric Phage Ghost Particles, Methods for Their Production and Use
#40Method of treating condition in animal
#41Fusion proteins comprising bacteriophage coat protein and asingle-chain T cell receptor
#42Drug delivery nanocarriers targeted by landscape phage
#43Development of novel anti-microbial agents based on bacteriophage genomics
#44Genomic library of cyanophage s-2l and functional analysis
#45Methods and compositions for modulating conditions in both mammals and plants
#46Production of recombinant protein pap 31 for the diagnosis and prevention of infection
#47Thermostable RNA ligase from thermus phage
#48Protein
#49Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
#50Methods of selecting internalizing antibodies
#51Chimaeric phages
#52Phage-associated lytic enzymes for treatment of and related conditions
#53Surface expression libraries of heteromeric receptors